Research
Hormonal
Two-thirds of respondents reported reduced appetite, food cravings, or body weight.
Practitioners can expect that a significant portion of patients may experience appetite reduction and weight loss with Ozempic.
StrongSupportsmedium confidence
Two-thirds of respondents reported reduced appetite, food cravings, or body weight.
Why this rating
Based on the analysis of user reviews, which provides substantial qualitative data.
Source
Patient Perceptions of Ozempic (Semaglutide) for Weight Loss: Mixed Methods Analysis of Online Medication Reviews
Abanoub Armanious et al. · Journal of Medical Internet Research · 2025
DOI 10.2196/78391
other · n=60Cited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →